MARK G FOLETTA Insider Trading $AMLN AMYLIN PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK G FOLETTA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK G FOLETTA. MARK G FOLETTA is Senior VP, Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP & Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Director in AMN HEALTHCARE SERVICES INC ($AHS) and Director in DEXCOM INC ($DXCM) and Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Interim CFO in BIOCEPT INC ($BIOC) and EVP & Chief Financial Officer in Tocagen Inc ($TOCA) and Director in Regulus Therapeutics Inc. ($RGLS).
MARK G FOLETTA in AMYLIN PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: SVP, Chief Financial Officer, SVP Chief Financial Officer, Sr VP Finance & CFO, Senior VP, Finance & CFO, VP Finance & CFO, VP & Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Aug 10 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK G FOLETTA in AMYLIN PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AHS, AMLN, BIOC, DXCM, ENTA, TOCA, RGLS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 0.00 | 40,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 41.34 | 46,799 | 1,934,671 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 36.90 | 67,289 | 2,482,964 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 24.87 | 65,980 | 1,640,923 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 22.60 | 34,884 | 788,378 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.85 | 23,722 | 447,160 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.01 | 44,243 | 796,816 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.54 | 35,475 | 586,757 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.02 | 112,207 | 1,797,556 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 15.03 | 70,843 | 1,064,770 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 9.02 | 56,248 | 507,357 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 41.34 | 3,201 | 132,329 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 36.90 | 2,711 | 100,036 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 24.87 | 4,020 | 99,977 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 22.60 | 5,116 | 115,622 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.85 | 8,361 | 157,605 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.01 | 5,757 | 103,684 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.54 | 4,525 | 74,844 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.02 | 7,793 | 124,844 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 15.03 | 9,157 | 137,630 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 9.02 | 3,752 | 33,843 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 110 | 3,410 | 0 | 110 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 2,889 | 89,559 | 0 | 2.9 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 5,085 | 157,635 | 2,889 | 8 K to 2.9 K (-63.77 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 3,415 | 105,865 | 0 | 3.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 453 | 14,043 | 3,415 | 3.9 K to 3.4 K (-11.71 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | J | 31.00 | 64,702 | 2,005,762 | 0 | 64.7 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 65,115 | 2,018,565 | 64,702 | 129.8 K to 64.7 K (-50.16 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 8,255 | 255,905 | 129,817 | 138.1 K to 129.8 K (-5.98 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Buy | J | 31.00 | 64,702 | 2,005,762 | 138,072 | 73.4 K to 138.1 K (+88.19 %) |
| Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 14.62 | 880 | 12,866 | 73,370 | 72.5 K to 73.4 K (+1.21 %) |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | A | 16.02 | 112,207 | 1,797,556 | 112,207 | |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | A | 16.02 | 7,793 | 124,844 | 7,793 | |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 0.00 | 1,529 | 0 | 7,974 | 6.4 K to 8 K (+23.72 %) |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 0.00 | 10,000 | 0 | 72,490 | 62.5 K to 72.5 K (+16.00 %) |
| Mar 02 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | S | 17.11 | 1,846 | 31,585 | 62,490 | 64.3 K to 62.5 K (-2.87 %) |
| Feb 24 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | S | 17.03 | 5,638 | 96,016 | 63,439 | 69.1 K to 63.4 K (-8.16 %) |
| Feb 24 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 0.00 | 15,000 | 0 | 69,077 | 54.1 K to 69.1 K (+27.74 %) |
| Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Payment of Exercise | F | 16.47 | 3,122 | 51,419 | 54,565 | 57.7 K to 54.6 K (-5.41 %) |
| Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 0.00 | 8,000 | 0 | 57,687 | 49.7 K to 57.7 K (+16.10 %) |
| Jan 12 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 0.00 | 7,500 | 0 | 49,687 | 42.2 K to 49.7 K (+17.78 %) |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | A | 15.03 | 70,843 | 1,064,770 | 70,843 | |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | A | 15.03 | 9,157 | 137,630 | 9,157 | |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 0.00 | 1,630 | 0 | 6,445 | 4.8 K to 6.4 K (+33.85 %) |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Grant | A | 0.00 | 15,000 | 0 | 41,457 | 26.5 K to 41.5 K (+56.70 %) |
| Apr 06 2010 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | M | 13.25 | 638 | 8,454 | 0 | |
| Apr 06 2010 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Buy | M | 13.25 | 638 | 8,454 | 28,138 | 27.5 K to 28.1 K (+2.32 %) |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP Chief Financia ... | Option Exercise | A | 18.01 | 44,243 | 796,816 | 44,243 | |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP Chief Financia ... | Option Exercise | A | 18.01 | 5,757 | 103,684 | 5,757 | |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP Chief Financia ... | Grant | A | 0.00 | 1,360 | 0 | 4,815 | 3.5 K to 4.8 K (+39.36 %) |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP Chief Financia ... | Grant | A | 17.83 | 412 | 7,346 | 26,412 | 26 K to 26.4 K (+1.58 %) |
| Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Option Exercise | A | 9.02 | 56,248 | 507,357 | 86,248 | |
| Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Option Exercise | A | 9.02 | 30,000 | 270,600 | 30,000 | |
| Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Option Exercise | A | 9.02 | 3,752 | 33,843 | 3,752 | |
| Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
| Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Grant | A | 11.80 | 585 | 6,903 | 24,839 | 24.3 K to 24.8 K (+2.41 %) |
| Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 24.87 | 65,980 | 1,640,923 | 65,980 | |
| Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 24.87 | 4,020 | 99,977 | 4,020 | |
| Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Grant | A | 37.00 | 182 | 6,734 | 23,753 | 23.6 K to 23.8 K (+0.77 %) |
| Sep 28 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 3,000 | 39,750 | 638 | |
| Sep 28 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 49.98 | 3,000 | 149,932 | 23,242 | 26.2 K to 23.2 K (-11.43 %) |
| Sep 28 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 3,000 | 39,750 | 26,242 | 23.2 K to 26.2 K (+12.91 %) |
| Aug 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 3,000 | 39,750 | 3,638 | |
| Aug 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 48.86 | 3,000 | 146,575 | 23,242 | 26.2 K to 23.2 K (-11.43 %) |
| Aug 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 3,000 | 39,750 | 26,242 | 23.2 K to 26.2 K (+12.91 %) |
| Aug 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 3,500 | 46,375 | 6,638 | |
| Aug 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 47.43 | 3,500 | 166,022 | 23,242 | 26.7 K to 23.2 K (-13.09 %) |
| Aug 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 3,500 | 46,375 | 26,742 | 23.2 K to 26.7 K (+15.06 %) |
| Jul 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 2,500 | 33,125 | 10,138 | |
| Jul 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 41.38 | 2,500 | 103,455 | 23,242 | 25.7 K to 23.2 K (-9.71 %) |
| Jul 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 2,500 | 33,125 | 25,742 | 23.2 K to 25.7 K (+10.76 %) |
| Jun 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 6,500 | 86,125 | 12,638 | |
| Jun 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 45.79 | 6,500 | 297,663 | 23,242 | 29.7 K to 23.2 K (-21.85 %) |
| Jun 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 6,500 | 86,125 | 29,742 | 23.2 K to 29.7 K (+27.97 %) |
| May 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 2,500 | 33,125 | 19,138 | |
| May 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 42.32 | 2,500 | 105,800 | 23,242 | 25.7 K to 23.2 K (-9.71 %) |
| May 01 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 2,500 | 33,125 | 25,742 | 23.2 K to 25.7 K (+10.76 %) |
| Apr 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 2,500 | 33,125 | 21,638 | |
| Apr 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 37.61 | 2,500 | 94,025 | 23,242 | 25.7 K to 23.2 K (-9.71 %) |
| Apr 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 2,500 | 33,125 | 25,742 | 23.2 K to 25.7 K (+10.76 %) |
| Mar 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 36.90 | 67,289 | 2,482,964 | 67,289 | |
| Mar 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 36.90 | 2,711 | 100,036 | 2,711 | |
| Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 2,486 | 32,940 | 24,138 | |
| Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.95 | 14 | 167 | 0 | |
| Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 38.82 | 2,486 | 96,507 | 23,242 | 25.7 K to 23.2 K (-9.66 %) |
| Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 2,486 | 32,940 | 25,728 | 23.2 K to 25.7 K (+10.70 %) |
| Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 38.82 | 14 | 543 | 23,242 | 23.3 K to 23.2 K (-0.06 %) |
| Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.95 | 14 | 167 | 23,256 | 23.2 K to 23.3 K (+0.06 %) |
| Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Grant | A | 33.07 | 232 | 7,673 | 23,242 | 23 K to 23.2 K (+1.01 %) |
| Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Grant | A | 36.07 | 416 | 15,005 | 23,010 | 22.6 K to 23 K (+1.84 %) |
| Jan 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.95 | 2,500 | 29,875 | 14 | |
| Jan 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 39.00 | 2,500 | 97,500 | 22,594 | 25.1 K to 22.6 K (-9.96 %) |
| Jan 31 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.95 | 2,500 | 29,875 | 25,094 | 22.6 K to 25.1 K (+11.06 %) |
| Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.95 | 2,500 | 29,875 | 2,514 | |
| Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 35.89 | 2,500 | 89,725 | 22,594 | 25.1 K to 22.6 K (-9.96 %) |
| Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.95 | 2,500 | 29,875 | 25,094 | 22.6 K to 25.1 K (+11.06 %) |
| Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.95 | 1,236 | 14,770 | 5,014 | |
| Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.13 | 1,264 | 14,062 | 0 | |
| Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 40.76 | 1,236 | 50,379 | 22,594 | 23.8 K to 22.6 K (-5.19 %) |
| Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.95 | 1,236 | 14,770 | 23,830 | 22.6 K to 23.8 K (+5.47 %) |
| Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 40.76 | 1,264 | 51,521 | 22,594 | 23.9 K to 22.6 K (-5.30 %) |
| Dec 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.13 | 1,264 | 14,062 | 23,858 | 22.6 K to 23.9 K (+5.59 %) |
| Nov 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.13 | 2,500 | 27,813 | 1,264 | |
| Nov 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 43.91 | 2,500 | 109,775 | 22,594 | 25.1 K to 22.6 K (-9.96 %) |
| Nov 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.13 | 2,500 | 27,813 | 25,094 | 22.6 K to 25.1 K (+11.06 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.13 | 923 | 10,268 | 3,764 | |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 9.88 | 1,077 | 10,635 | 0 | |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 44.35 | 923 | 40,936 | 22,594 | 23.5 K to 22.6 K (-3.92 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.13 | 923 | 10,268 | 23,517 | 22.6 K to 23.5 K (+4.09 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 44.35 | 1,077 | 47,766 | 22,594 | 23.7 K to 22.6 K (-4.55 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 9.88 | 1,077 | 10,635 | 23,671 | 22.6 K to 23.7 K (+4.77 %) |
| Aug 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 9.88 | 2,000 | 19,750 | 1,077 | |
| Aug 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 41.76 | 2,000 | 83,520 | 21,788 | 23.8 K to 21.8 K (-8.41 %) |
| Aug 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 9.88 | 2,000 | 19,750 | 23,788 | 21.8 K to 23.8 K (+9.18 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 267 | 3,538 | 0 | |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 9.88 | 1,733 | 17,113 | 3,077 | |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 48.38 | 1,733 | 83,847 | 21,788 | 23.5 K to 21.8 K (-7.37 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 9.88 | 1,733 | 17,113 | 23,521 | 21.8 K to 23.5 K (+7.95 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 48.38 | 267 | 12,918 | 21,788 | 22.1 K to 21.8 K (-1.21 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 267 | 3,538 | 22,055 | 21.8 K to 22.1 K (+1.23 %) |
| Jun 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 2,000 | 26,500 | 267 | |
| Jun 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 43.00 | 2,000 | 86,000 | 21,788 | 23.8 K to 21.8 K (-8.41 %) |
| Jun 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 2,000 | 26,500 | 23,788 | 21.8 K to 23.8 K (+9.18 %) |
| May 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 41.34 | 46,799 | 1,934,671 | 46,799 | |
| May 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 41.34 | 3,201 | 132,329 | 3,201 | |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 13.25 | 1,109 | 14,694 | 2,267 | |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 11.95 | 200 | 2,390 | 0 | |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 9.63 | 666 | 6,410 | 0 | |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 9.63 | 25 | 241 | 666 | |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 42.75 | 1,109 | 47,410 | 21,788 | 22.9 K to 21.8 K (-4.84 %) |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 13.25 | 1,109 | 14,694 | 22,897 | 21.8 K to 22.9 K (+5.09 %) |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 42.75 | 666 | 28,472 | 21,788 | 22.5 K to 21.8 K (-2.97 %) |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 9.63 | 666 | 6,410 | 22,454 | 21.8 K to 22.5 K (+3.06 %) |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 42.75 | 200 | 8,550 | 21,788 | 22 K to 21.8 K (-0.91 %) |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 11.95 | 200 | 2,390 | 21,988 | 21.8 K to 22 K (+0.92 %) |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 42.75 | 25 | 1,069 | 21,788 | 21.8 K to 21.8 K (-0.11 %) |
| May 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 9.63 | 25 | 241 | 21,813 | 21.8 K to 21.8 K (+0.11 %) |
| Apr 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 9.63 | 1,000 | 9,625 | 691 | |
| Apr 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 9.63 | 1,000 | 9,625 | 1,691 | |
| Apr 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 48.84 | 1,000 | 48,840 | 21,788 | 22.8 K to 21.8 K (-4.39 %) |
| Apr 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 9.63 | 1,000 | 9,625 | 22,788 | 21.8 K to 22.8 K (+4.59 %) |
| Apr 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 48.84 | 1,000 | 48,840 | 21,788 | 22.8 K to 21.8 K (-4.39 %) |
| Apr 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 9.63 | 1,000 | 9,625 | 22,788 | 21.8 K to 22.8 K (+4.59 %) |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 9.63 | 642 | 6,179 | 2,691 | |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 9.63 | 1,567 | 15,082 | 3,333 | |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 291 | 1,667 | 0 | |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 43.91 | 642 | 28,190 | 27,048 | 27.7 K to 27 K (-2.32 %) |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 9.63 | 642 | 6,179 | 27,690 | 27 K to 27.7 K (+2.37 %) |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 43.91 | 1,567 | 68,807 | 27,048 | 28.6 K to 27 K (-5.48 %) |
| Mar 16 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 9.63 | 1,567 | 15,082 | 28,615 | 27 K to 28.6 K (+5.79 %) |